Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden

被引:83
作者
Frisk, G. [1 ]
Svensson, T. [1 ]
Backlund, L. M. [2 ]
Lidbrink, E. [3 ]
Blomqvist, P. [1 ]
Smedby, K. E. [1 ]
机构
[1] Karolinska Inst Solna, Clin Epidemiol Unit, Dept Med Solna, S-17176 Stockholm, Sweden
[2] Karolinska Inst Solna, Unit Expt Cardiovasc Res, Dept Med Solna, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, S-17176 Stockholm, Sweden
关键词
breast cancer; brain metastases; incidence; EPIDEMIOLOGY; CARCINOMA; SYSTEM; RISK;
D O I
10.1038/bjc.2012.163
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: While treatment for breast cancer has been refined and overall survival has improved, there is concern that the incidence of brain metastases has increased. METHODS: We identified patients in Sweden with incident breast cancer 1998-2006 in the National Cancer Register, and matched these to the National Patient Register to obtain information on hospital admissions for distant metastases. Hazard ratios (HRs) and 95% confidence intervals (CIs) were computed with Cox regression as estimates of relative risk. RESULTS: Among 50 528 breast cancer patients, 696 (1.4%) were admitted with brain metastases during median 3.5 years of follow-up. Admissions for other metastases were found in 3470 (6.9%) patients. Compared with the period 1998-2000, patients diagnosed with breast cancer 2004-2006 were at a 44% increased risk of being admitted with brain metastases (HR 1.44, 95% CI 1.13-1.85). CONCLUSION: The incidence of admissions with brain metastases in breast cancer patients was increasing in the mid-2000s in Sweden. These findings support a true increase in incidence of brain metastases among breast cancer patients. British Journal of Cancer (2012) 106, 1850-1853. doi:10.1038/bjc.2012.163 www.bjcancer.com Published online 24 April 2012 (C) 2012 Cancer Research UK
引用
收藏
页码:1850 / 1853
页数:4
相关论文
共 15 条
[1]   The completeness of the Swedish Cancer Register - a sample survey for year 1998 [J].
Barlow, Lotti ;
Westergren, Kerstin ;
Holmberg, Lars ;
Talback, Mats .
ACTA ONCOLOGICA, 2009, 48 (01) :27-33
[2]   Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Davis, FG ;
Vigneau, FD ;
Lai, P ;
Sawaya, RE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872
[3]   Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden [J].
Foukakis, Theodoros ;
Fornander, Tommy ;
Lekberg, Tobias ;
Hellborg, Henrik ;
Adolfsson, Jan ;
Bergh, Jonas .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) :553-560
[4]   Brain metastases: epidemiology and pathophysiology [J].
Gavrilovic, IT ;
Posner, JB .
JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (01) :5-14
[5]  
Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1
[6]   The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma [J].
Lai, R ;
Dang, CT ;
Malkin, MG ;
Abrey, LE .
CANCER, 2004, 101 (04) :810-816
[7]   Brain metastases: The HER2 paradigm [J].
Lin, Nancy U. ;
Winer, Eric P. .
CLINICAL CANCER RESEARCH, 2007, 13 (06) :1648-1655
[8]  
*NAT BOARD HLTH WE, 2011, CANC INC SWED 2009
[9]  
OECD Health Data, 2005, OECD HLTH DAT
[10]   Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis [J].
Pelletier, Elise M. ;
Shim, Boyung ;
Goodman, Seth ;
Amonkar, Mayur M. .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) :297-305